"/> IBA Lifesciences SARS-CoV-2 Peptide LALLLLDRL (HLA-A*020… | B-LABO France

IBA Lifesciences SARS-CoV-2 Peptide LALLLLDRL (HLA-A*0201)

Réf. : BL-RE-056436Réf. fabricant : 16674744 1 mg
70,50 € HT

Single peptide synthesized as presented by the MHC class I allele

Pureté
>85%
Niveau d’endotoxines
Free
Format
Lyophilized Powder
Quantité
1 mg
Catégorie de recherche
T cell stimulation
Marque
IBA Lifesciences

Caractéristiques principales

  • SARS-CoV-2 peptide ILLNKHIDA (HLA-A*0201) is a single peptide for stimulation of T cells.
  • The peptide from SARS-CoV-2 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.
  • The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Caractéristiques techniques

MarqueIBA Lifesciences
Réf. B-LABOBL-RE-056436
Réf. fabricant16674744
Pureté>85%
Niveau d’endotoxinesFree
FormatLyophilized Powder
Quantité1 mg
Catégorie de rechercheT cell stimulation
Une question, une configuration particulière ?
Contactez-nous pour un devis.
Demander un devis 03 65 67 15 79

Produits similaires

IBA Lifesciences SARS-CoV-2 Peptide VLNDILSRL (HLA-A*0201)

IBA Lifesciences SARS-CoV-2 Peptide VLNDILSRL (HLA-A*0201)

70,50 € HT
IBA Lifesciences CMV pp50 peptide VTEHDTLLY (HLA-A*0101)

IBA Lifesciences CMV pp50 peptide VTEHDTLLY (HLA-A*0101)

67,32 € HT
IBA Lifesciences Influenza M peptide GILGFVFTL (HLA-A*0201)

IBA Lifesciences Influenza M peptide GILGFVFTL (HLA-A*0201)

70,50 € HT
IBA Lifesciences™ Survivin Peptide ELTLGEFLKL (HLA-A*0201)

IBA Lifesciences™ Survivin Peptide ELTLGEFLKL (HLA-A*0201)

68,55 € HT